NO20061246L - Salter og polymorfe former av en pyrrol-substituert indolinonforbindelse - Google Patents
Salter og polymorfe former av en pyrrol-substituert indolinonforbindelseInfo
- Publication number
- NO20061246L NO20061246L NO20061246A NO20061246A NO20061246L NO 20061246 L NO20061246 L NO 20061246L NO 20061246 A NO20061246 A NO 20061246A NO 20061246 A NO20061246 A NO 20061246A NO 20061246 L NO20061246 L NO 20061246L
- Authority
- NO
- Norway
- Prior art keywords
- salts
- pyrrole
- polymorphic forms
- indolinone compound
- substituted indolinone
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 abstract 2
- CTNPALGJUAXMMC-PMFHANACSA-N 5-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-n-[(2s)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide Chemical compound C([C@@H](O)CNC(=O)C=1C(C)=C(\C=C/2C3=CC(F)=CC=C3NC\2=O)NC=1C)N1CCOCC1 CTNPALGJUAXMMC-PMFHANACSA-N 0.000 abstract 1
- -1 5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene Chemical group 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002688 maleic acid derivatives Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50810403P | 2003-10-02 | 2003-10-02 | |
| PCT/IB2004/003070 WO2005033098A1 (en) | 2003-10-02 | 2004-09-20 | Salts and polymorphs of a pyrrole-substituted indolinone compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061246L true NO20061246L (no) | 2006-03-29 |
Family
ID=34421700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061246A NO20061246L (no) | 2003-10-02 | 2006-03-17 | Salter og polymorfe former av en pyrrol-substituert indolinonforbindelse |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7247627B2 (pt) |
| EP (1) | EP1670785B1 (pt) |
| JP (1) | JP4933259B2 (pt) |
| KR (2) | KR20080007520A (pt) |
| CN (1) | CN100432072C (pt) |
| AR (1) | AR047762A1 (pt) |
| AT (1) | ATE473223T1 (pt) |
| AU (1) | AU2004277464B2 (pt) |
| BR (1) | BRPI0415022A (pt) |
| CA (1) | CA2540639C (pt) |
| CY (1) | CY1110771T1 (pt) |
| DE (1) | DE602004028028D1 (pt) |
| DK (1) | DK1670785T3 (pt) |
| ES (1) | ES2348623T3 (pt) |
| IL (1) | IL174414A (pt) |
| MX (1) | MXPA06003661A (pt) |
| NO (1) | NO20061246L (pt) |
| NZ (1) | NZ546001A (pt) |
| PL (1) | PL1670785T3 (pt) |
| PT (1) | PT1670785E (pt) |
| RU (1) | RU2319702C2 (pt) |
| SI (1) | SI1670785T1 (pt) |
| TW (1) | TW200524921A (pt) |
| WO (1) | WO2005033098A1 (pt) |
| ZA (1) | ZA200602691B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050182122A1 (en) * | 2003-11-20 | 2005-08-18 | Bello Carlo L. | Method of treating abnormal cell growth using indolinone compounds |
| MX2007011767A (es) * | 2005-03-23 | 2007-10-18 | Pfizer Prod Inc | Terapia de combinacion de anticuerpo anti-ctla4 e indolinona para el tratamiento del cancer. |
| KR20080040007A (ko) * | 2005-09-20 | 2008-05-07 | 화이자 프로덕츠 인크. | 티로신 키나제 억제제를 이용한 치료의 투여형 및 방법 |
| CL2008000070A1 (es) * | 2007-01-17 | 2008-07-25 | Lg Life Sciences Ltd | Monosal del acido maleico (3-[({1-[(2-amino-9h-purin-9-il)metil]ciclopropil}oxi)metil]-8,8-dimetil-3,7-dioxo-2,4,6-trioxa-3 lambda 5-fosfanon-1-il-pivalato; composicion farmaceutica que comprende a dicha monosal; y uso para el tratamiento del virus h |
| EP2130798B1 (en) * | 2007-04-04 | 2018-05-16 | Otsuka Chemical Co., Ltd. | Potassium titanate, process for production of the same, friction materials, and resin compositions |
| PE20110292A1 (es) * | 2008-09-17 | 2011-05-17 | Novartis Ag | Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida |
| RU2430361C1 (ru) * | 2010-07-05 | 2011-09-27 | Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет им. В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" | Способ прогнозирования риска развития диабетической ретинопатии при сахарном диабете типа 2 у якутов |
| WO2012042421A1 (en) | 2010-09-29 | 2012-04-05 | Pfizer Inc. | Method of treating abnormal cell growth |
| US9851313B2 (en) * | 2015-03-03 | 2017-12-26 | Panalytical B.V. | Quantitative X-ray analysis—ratio correction |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1575936A3 (ru) * | 1986-04-10 | 1990-06-30 | Е.И.Дюпон Де Немур Энд Ко.(Фирма) | Способ получени 3,3-дизамещенных индолин-2-ионов или их солей |
| US5534522A (en) * | 1995-06-07 | 1996-07-09 | Warner-Lambert Company | (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent |
| DE19622489A1 (de) * | 1996-06-05 | 1997-12-11 | Hoechst Ag | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters |
| JP3663382B2 (ja) * | 2000-02-15 | 2005-06-22 | スージェン・インコーポレーテッド | ピロール置換２−インドリノン蛋白質キナーゼ阻害剤 |
| AR042586A1 (es) * | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
| CN100364991C (zh) | 2001-08-15 | 2008-01-30 | 法玛西雅厄普约翰美国公司 | 2,4-二甲基-1h-吡咯-3-甲酰胺衍生物的苹果酸盐的晶体、其制备方法和其组合物 |
| YU67702A (sh) | 2001-09-28 | 2004-12-31 | Pfizer Products Inc. | Postupak za dobijanje alkansulfonil piridina |
| TWI259081B (en) * | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
| US7119209B2 (en) * | 2002-02-15 | 2006-10-10 | Pharmacia & Upjohn Company | Process for preparing indolinone derivatives |
| TW200418836A (en) * | 2002-09-10 | 2004-10-01 | Pharmacia Italia Spa | Formulations comprising an indolinone compound |
-
2004
- 2004-09-20 NZ NZ546001A patent/NZ546001A/en unknown
- 2004-09-20 RU RU2006110541/04A patent/RU2319702C2/ru not_active IP Right Cessation
- 2004-09-20 KR KR1020087000428A patent/KR20080007520A/ko not_active Ceased
- 2004-09-20 SI SI200431486T patent/SI1670785T1/sl unknown
- 2004-09-20 PT PT04769435T patent/PT1670785E/pt unknown
- 2004-09-20 DE DE602004028028T patent/DE602004028028D1/de not_active Expired - Lifetime
- 2004-09-20 CA CA2540639A patent/CA2540639C/en not_active Expired - Fee Related
- 2004-09-20 WO PCT/IB2004/003070 patent/WO2005033098A1/en not_active Ceased
- 2004-09-20 DK DK04769435.1T patent/DK1670785T3/da active
- 2004-09-20 MX MXPA06003661A patent/MXPA06003661A/es active IP Right Grant
- 2004-09-20 AU AU2004277464A patent/AU2004277464B2/en not_active Ceased
- 2004-09-20 CN CNB2004800287364A patent/CN100432072C/zh not_active Expired - Fee Related
- 2004-09-20 KR KR1020067006363A patent/KR20060058728A/ko not_active Ceased
- 2004-09-20 BR BRPI0415022-8A patent/BRPI0415022A/pt not_active IP Right Cessation
- 2004-09-20 ES ES04769435T patent/ES2348623T3/es not_active Expired - Lifetime
- 2004-09-20 PL PL04769435T patent/PL1670785T3/pl unknown
- 2004-09-20 EP EP04769435A patent/EP1670785B1/en not_active Expired - Lifetime
- 2004-09-20 AT AT04769435T patent/ATE473223T1/de active
- 2004-09-20 JP JP2006530728A patent/JP4933259B2/ja not_active Expired - Fee Related
- 2004-09-30 US US10/956,420 patent/US7247627B2/en not_active Expired - Fee Related
- 2004-10-01 TW TW093129924A patent/TW200524921A/zh unknown
- 2004-10-01 AR ARP040103580A patent/AR047762A1/es not_active Application Discontinuation
-
2006
- 2006-03-17 NO NO20061246A patent/NO20061246L/no not_active Application Discontinuation
- 2006-03-20 IL IL174414A patent/IL174414A/en not_active IP Right Cessation
- 2006-03-31 ZA ZA200602691A patent/ZA200602691B/en unknown
-
2010
- 2010-09-03 CY CY20101100810T patent/CY1110771T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2019005I1 (no) | N-[2-(dietylamino)etyl]-5-[(Z)-(5-fluoro-2-okso-1,2-dihydro-3H-indol-3-yliden)metyl]-2,4-dimetyl-1H-pyrrol-3-karboksamid (sunitinib), samt farmasøytisk akseptable salter | |
| NO20071290L (no) | Enantiomert rene aminoheteroarylforbindelser som protein kinase inhibitorer | |
| UA107175C2 (uk) | Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти | |
| NO20071320L (no) | Pyrazolsubstituerte aminoheteroarylforbindelser som protein kinase inhibitorer. | |
| GB2431927A9 (en) | 1,2-Disubstituted indoles & derivatives thereof astherapeutic 5-iipoxygenase-activating protein (fl ap) inhibitors | |
| NO20083918L (no) | Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser | |
| CY1110771T1 (el) | Αλατα και πολυμορφα μιας πυρρολο-υποκατεστημενης ινδολινονικης ενωσης | |
| EA200801381A1 (ru) | Производные пиримидина | |
| NO20071619L (no) | Fremgangsmate for fremstilling av indazol forbindelse | |
| NO20082338L (no) | Pyrimidinderivater for behandling av avvikende cellevekst | |
| PE20080362A1 (es) | Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1 | |
| DE60328028D1 (de) | Imidazolverbindungen als inhibitoren des transformierenden wachstumsfaktors (twf) | |
| EA201000486A1 (ru) | Ингибитор белка, активирующего 5-липоксигеназу (flap) | |
| EA200970604A1 (ru) | Новое промежуточное соединение и способ, используемый для получения {2-[1-(3,5-бис-трифторметилбензил)-5-пиридин-4-ил-1н-[1,2,3]триазол-4-ил]пиридин-3-ил}-(2-хлорфенил)метанона | |
| EA200970041A1 (ru) | Ингибиторы акт (протеинкиназы в) | |
| EP1628974A4 (en) | HYDANTOIN DERIVATIVES AS INHIBITORS OF THE TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME (TACE) | |
| AR049681A1 (es) | Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas | |
| PT1713801E (pt) | Processo para a preparação de 1-(2s,3s)-2-benzidril-n-(5- -terc-butil-2-metoxibenzil)-quinuclidina-3-amina | |
| EA200600898A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
| PL375415A1 (en) | Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide | |
| WO2005123670A3 (en) | Crystalline form of a substituted pyrrolidine compound | |
| MXPA05008959A (es) | Polimorfos de inhibidores de proteina cinasa de 2-indolinona sustituidos con pirrolo. | |
| JP2010538009A5 (pt) | ||
| EA201000882A1 (ru) | Соединение, его применение и фармацевтическая композиция, содержащая это соединение | |
| MXPA04003085A (es) | Proceso estereoespecifico para sintesis de derivados de 2-il cromano. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |